Cerebral Kyle Robertson, CEO and co-founder of Digital Mental Health, is leaving his position amid growing controversy over his prescription practice for controlled substances, especially adrenaline.
Dr. David Mau, who has served as president and chief medical officer of Cerebral, will immediately take over as acting CEO. He added The role of the President earlier this month. In addition to the CEO shakeup, Chief Operating Officer Jessica Muse will now take over the presidency and will join the board of Thomas Insell, former director of the National Institute of Mental Health and the company’s clinical adviser, Cerebral.
The The Wall Street Journal And Bloomberg The board reportedly agreed to replace Robertson last night. According to WSJRobertson did not attend the meeting and lost access to the cerebral slack messaging system without prior notice.
Why it matters
Over the past few months, there has been increasing scrutiny over his prescribed practice for cerebral controlled substance. At the end of April, the former executive said Has sued the company, alleging that he was fired after raising patient safety concerns. She said she aims to prescribe medication to all her ADHD patients to increase cerebral retention. In a statement, the mental health agency said it believed the allegations were “without merit.”
At the beginning of this month, the company said Has confirmed that it has received a grand jury subpoena from the U.S. Attorney’s Office for the Eastern District of New York as part of an investigation into possible violations of the Controlled Substances Act.
At about the same time, the cerebral will have it Pause for prescriptions of controlled substances in new patients. This week, the Digital Mental Health Agency confirmed that it will stop prescribing the most controlled substances for both new and existing patients, although it will continue to provide medications to treat opioid use disorders.
On the record
“We thank Kyle for his services. His vision is what Cerebral Today is: a leading provider of urgently needed mental health services for those unable or unwilling to receive treatment,” Mau said in a statement.
“The timing was unfortunate for him. When the epidemic hit, cerebral mental health services became a lifeline for those in need. Kyle later led the company through rapid growth, helping thousands of patients access effective and safe care. Entering the next stage, we look forward to expanding our services, always guided by evidence-based clinical protocols to help those who are silently fighting mental health concerns. “